loader
Please Wait
Applying Filters...

EuroAPI Header EuroAPI Header

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Nipradilol, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Nipradilol

    APIs // Active Pharmaceutical Ingredients

    PharmaCompass

    With Fermion, start the journey of your innovative API.

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    2D Structure
    1. Also known as: Nipradolol, 81486-22-8, Hypadil, Hypadil (tn), K 351, Fvm336i71y
    Molecular Formula
    C15H22N2O6
    Molecular Weight
    326.34  g/mol
    InChI Key
    OMCPLEZZPVJJIS-UHFFFAOYSA-N
    FDA UNII
    FVM336I71Y
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    [8-[2-hydroxy-3-(propan-2-ylamino)propoxy]-3,4-dihydro-2H-chromen-3-yl] nitrate
    2.1.2 InChI
    InChI=1S/C15H22N2O6/c1-10(2)16-7-12(18)8-21-14-5-3-4-11-6-13(23-17(19)20)9-22-15(11)14/h3-5,10,12-13,16,18H,6-9H2,1-2H3
    2.1.3 InChI Key
    OMCPLEZZPVJJIS-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    CC(C)NCC(COC1=CC=CC2=C1OCC(C2)O[N+](=O)[O-])O
    2.2 Other Identifiers
    2.2.1 UNII
    FVM336I71Y
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. 3,4-dihydro-8-(2-hydroxy-3--isopropylaminopropoxy)-3-nitroxy-2h-1-benzopyran

    2. K 351

    3. K-351

    2.3.2 Depositor-Supplied Synonyms

    1. Nipradolol

    2. 81486-22-8

    3. Hypadil

    4. Hypadil (tn)

    5. K 351

    6. Fvm336i71y

    7. 8-(2-hydroxy-3-(isopropylamino)propoxy)chroman-3-yl Nitrate

    8. 8-(2-hydroxy-3-(isopropylamino)propoxy)-3-chromanol, 3-nitrate

    9. [8-[2-hydroxy-3-(propan-2-ylamino)propoxy]-3,4-dihydro-2h-chromen-3-yl] Nitrate

    10. Hypadil; K 351; Kt 210; Nipradilo

    11. Nipradilolum [latin]

    12. Nipradilolum

    13. Nipradilol [inn:jan]

    14. Ccris 2515

    15. Brn 3566879

    16. Unii-fvm336i71y

    17. Nipranol

    18. 8-(2-hydroxy-3-(isopropylamino)propoxy)-3-chromanyl Nitrat

    19. Nipradilol [mi]

    20. 8-(2-hydroxy-3-(isopropylamino)propoxy)-3-chromanol 3-nitrate

    21. Nipradilol (jan/inn)

    22. Nipradilol [inn]

    23. Nipradilol [jan]

    24. Nipradilol [inci]

    25. K-351

    26. 3,4-dihydro-8-(2-hydroxy-3-isopropylamino)propoxy-3-nitroxy-2h-1-benzopyran

    27. Nipradilol [mart.]

    28. 3,4-dihydro-8-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-2h-1-benzopyran-3-ol 3-nitrate

    29. 3,4-dihydro-8-(2-hydroxy-3-(isopropylamino)propoxy)-2h-1-benzopyran-3-ol 3-nitrate

    30. Nipradolol [who-dd]

    31. Schembl48884

    32. Chembl155622

    33. Chebi:31682

    34. Dtxsid30868615

    35. Bcp04466

    36. Kt-210

    37. Akos016014067

    38. 2h-1-benzopyran-3-ol, 3,4-dihydro-8-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-, 3-nitrate

    39. Ft-0630894

    40. D01691

    41. L013397

    42. Q15634005

    43. 3,4-dihydro-8-(2-hydroxy-3-isopropylaminopropoxy)-3-nitroxy-2h-1-benzopyran

    44. 3-nitroxy-8-[(2-hydroxy-3-isopropylamino)propoxy]-3,4(2h)-dihydro-1-benzopyran

    45. 8-[2-hydroxy-3-(isopropylamino)propoxy]-3,4-dihydro-2h-chromen-3-yl Nitrate #

    46. 8-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}-3,4-dihydro-2h-1-benzopyran-3-yl Nitrate

    2.4 Create Date
    2005-03-27
    3 Chemical and Physical Properties
    Molecular Weight 326.34 g/mol
    Molecular Formula C15H22N2O6
    XLogP32
    Hydrogen Bond Donor Count2
    Hydrogen Bond Acceptor Count7
    Rotatable Bond Count7
    Exact Mass326.14778643 g/mol
    Monoisotopic Mass326.14778643 g/mol
    Topological Polar Surface Area106 Ų
    Heavy Atom Count23
    Formal Charge0
    Complexity376
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count2
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Pharmacology and Biochemistry
    4.1 MeSH Pharmacological Classification

    Antihypertensive Agents

    Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)

    Vasodilator Agents

    Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)

    Adrenergic alpha-Antagonists

    Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. (See all compounds classified as Adrenergic alpha-Antagonists.)

    Adrenergic beta-Antagonists

    Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. (See all compounds classified as Adrenergic beta-Antagonists.)

    Post Enquiry
    POST ENQUIRY